Another point to note is that it was only Q2 2024 that Resmed had 529,000 patients in their cohort with prescriptions for both GLP-1 medications and positive airway pressure therapy. They're now up to 660,000 patients in their cohort. That's an additional 130,000 patients! I wouldn't brush over this lightly folks.
A few months ago this article below was published. Apologies if this has already been posted, but well worth reading again.
https://www.morningstar.com.au/insights/stocks/248775/resmeds-impressive-earnings
And just as I highlighted, an untapped market awaits imv the wearable technology market.
Tony
- Forums
- ASX - By Stock
- RMD
- GLP-1 and OSA
GLP-1 and OSA, page-89
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$32.66 |
Change
0.140(0.43%) |
Mkt cap ! $20.99B |
Open | High | Low | Value | Volume |
$32.56 | $32.67 | $32.41 | $33.93M | 1.040M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3261 | $32.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$32.66 | 11222 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62 | 32.500 |
1 | 1540 | 32.450 |
2 | 2100 | 32.300 |
2 | 392 | 32.200 |
1 | 500 | 32.020 |
Price($) | Vol. | No. |
---|---|---|
32.800 | 3000 | 1 |
32.970 | 154 | 1 |
32.990 | 100 | 1 |
33.000 | 5600 | 12 |
33.030 | 225 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |